Publikationen in Zusammenarbeit mit Forschern von Charité (22)

2023

  1. Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease

    Science translational medicine, Vol. 15, Núm. 712, pp. eabn5939

  2. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

    JAMA, Vol. 330, Núm. 13, pp. 1266-1277

  3. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

    European Journal of Preventive Cardiology, Vol. 30, Núm. 1, pp. 8-16

  4. Length-of-Stay in the Emergency Department and In-Hospital Mortality: A Systematic Review and Meta-Analysis

    Journal of Clinical Medicine, Vol. 12, Núm. 1

  5. The Association between Emergency Department Length of Stay and In-Hospital Mortality in Older Patients Using Machine Learning: An Observational Cohort Study

    Journal of Clinical Medicine, Vol. 12, Núm. 14

2022

  1. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. European Respiratory Society statement on sleep apnoea, sleepiness and driving risk

    European Respiratory Journal, Vol. 57, Núm. 2

  2. Obstructive sleep apnoea in adult patients post-tonsillectomy

    Sleep Medicine, Vol. 78, pp. 189-192

  3. The ANDANTE Project: A Worldwide Individual Data Meta-Analysis of the Effect of Sleep Apnea Treatment on Blood Pressure

    Archivos de Bronconeumologia

2020

  1. Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets

    EClinicalMedicine, Vol. 27

  2. Long-term positive airway pressure therapy is associated with reduced total cholesterol levels in patients with obstructive sleep apnea: data from the European Sleep Apnea Database (ESADA)

    Sleep Medicine, Vol. 75, pp. 201-209

  3. Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database

    Respirology, Vol. 25, Núm. 8, pp. 872-879

  4. Unique sleep-stage transitions determined by obstructive sleep apnea severity, age and gender

    Journal of Sleep Research, Vol. 29, Núm. 2

2019

  1. Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA)

    Sleep and Breathing, Vol. 23, Núm. 3, pp. 805-814

  2. Use of the Clinical Global Impression scale in sleep apnea patients – Results from the ESADA database

    Sleep Medicine, Vol. 59, pp. 56-65

2018

  1. Five-year risk of stroke after TIA or minor ischemic stroke

    New England Journal of Medicine, Vol. 378, Núm. 23, pp. 2182-2190

  2. Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database

    Respirology, Vol. 23, Núm. 12, pp. 1180-1189

  3. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

    The Lancet Neurology, Vol. 17, Núm. 12, pp. 1053-1060

2016

  1. Clinical phenotypes and comorbidity in European sleep apnoea patients

    PLoS ONE, Vol. 11, Núm. 10

2014

  1. Driving habits and risk factors for traffic accidents among sleep apnea patients - a European multi-centre cohort study

    Journal of Sleep Research, Vol. 23, Núm. 6, pp. 689-699